Адаптация русскоязычной версии методики Шкала оценки отношения к вакцинации (VAX) Л.Р. Мартин и К.Дж. Петри

The quest for more COVID-19 vaccinations in Africa

Understanding the determinants of acceptance of COVID-19 vaccines: a challenge in a fast-moving situation

Unraveling the association between vaccine attitude, vaccine conspiracies and self-reported side effects following COVID-19 vaccination among nurses and physicians in Jordan

Safety of COVID-19 vaccination in patients with clonal mast cell disorders

No Difference in Venous Thromboembolism Outcomes after COVID-19 and Influenza Vaccinations

Seroresponse to SARS-CoV-2 Vaccines Among Maintenance Dialysis Patients

Background:Vaccine hesitancy can limit the benefits of available vaccines in halting the spread of COVID-19 pandemic. Previously published studies paid little attention to Arab countries, which has a population of over 440 million. In this study, we present the results of the first large-scale multinational study that measures vaccine hesitancy among Arab-speaking subjects.Methods:An online survey in Arabic was conducted from 14 January 2021 to 29 January 2021. It consisted of 17 questions capturing demographic data, acceptance of COVID-19 vaccine, attitudes toward the need for COVID-19 vaccination and associated health policies, and reasons for vaccination hesitancy. R software v.4.0.2 was used for data analysis and visualization.Results:The survey recruited 36,220 eligible participants (61.1% males, 38.9% females, mean age 32.6 ± 10.8 years) from all the 23 Arab countries and territories (83.4%) and 122 other countries (16.6%). Our analysis shows a significant rate of vaccine hesitancy among Arabs in and outside the Arab region (83% and 81%, respectively). The most cited reasons for hesitancy are concerns about side effects and distrust in health care policies, vaccine expedited production, published studies and vaccine producing companies. We also found that female participants, those who are 30–59 years old, those with no chronic diseases, those with lower level of academic education, and those who do not know the type of vaccine authorized in their countries are more hesitant to receive COVID-19 vaccination. On the other hand, participants who regularly receive the influenza vaccine, health care workers, and those from countries with higher rates of COVID-19 infections showed more vaccination willingness. Interactive representation of our results is posted on our project website at https://mainapp.shinyapps.io/CVHAA.Conclusions:Our results show higher vaccine hesitancy and refusal among Arab subjects, related mainly to distrust and concerns about side effects. Health authorities and Arab scientific community have to transparently address these concerns to improve vaccine acceptance.Funding:This study received no funding.

Building on Success Serving the Nation: Codifying Key Pharmacy Practice Authorities Beyond COVID-19.

Safety of mRNA COVID-19 vaccines during pregnancy

Multiple evanescent white dot syndrome following COVID-19 vaccines

Background: On March 2020, the World Health Organization announced that coronavirus disease 2019 (COVID-19) has become a pandemic. In Iraq, since the start of applying the national COVID-19 vaccine campaign, many people refused to take the COVID-19 vaccine for various reasons, which has led to the further spread of the disease and the pandemic. Objectives: To determine some factors for refusing COVID-19 vaccination and the beliefs about the COVID-19 vaccine among Iraqi people in Anbar Province, Iraq. Subjects and Methods: A household-based cross-sectional study and a face-to-face interview were done on 814 participants who were involved in the survey. A convenient sample approach was followed in this study to recruit participants from 11 different areas in the entral, southern, and northern of Anbar Province, Iraq, including urban and rural regions. A questionnaire form was applied to participants enrolled in the study, and the principal researcher carried out a written interview by face-to-face with the participant. An analysis of data carried out using cross-tabulated chi square test to identify variables associated with vaccine acceptance, in addition to descriptive statistics. Results: A majority (71.7%) of the population did not take any type of COVID-19 vaccine; among those who took the COVID-19 vaccine, 58.4% took only one dose of vaccination. Among people who did not take any type of vaccine, a high percentage of 72.1% said that they did not trust it. Others (14.3%) did not take it because their friends and relatives did not take it. A significant difference (P = 0.001) was found regarding the characteristics of those who took the vaccine and those who did not take it, including age, gender, occupation, place of residence, education level, and having had COVID-19. Conclusion: A high prevalence of COVID-19 vaccine refusal was found in places in Anbar Governorate based on rumors, media communication, and behavioral attitudes needs many efforts from health workers in primary health-care centers and other health staff in other health institutions to increase people’s knowledge about the vaccine to lessen COVID-19 vaccine hesitancy.

Due to the COVID-19 pandemic, vaccine development and community vaccination studies are carried out all over the world. At this stage, the opposition to the vaccine seen in the society or the lack of trust in the developed vaccine is an important factor hampering vaccination activities. In this study, aspect-base sentiment analysis was conducted for USA, U.K., Canada, Turkey, France, Germany, Spain and Italy showing the approach of twitter users to vaccination and vaccine types during the COVID-19 period. Within the scope of this study, two datasets in English and Turkish were prepared with 928,402 different vaccine-focused tweets collected by country. In the classification of tweets, 4 different aspects (policy, health, media and other) and 4 different BERT models (mBERT-base, BioBERT, ClinicalBERT and BERTurk) were used. 6 different COVID-19 vaccines with the highest frequency among the datasets were selected and sentiment analysis was made by using Twitter posts regarding these vaccines. To the best of our knowledge, this paper is the first attempt to understand people's views about vaccination and types of vaccines. With the experiments conducted, the results of the views of the people on vaccination and vaccine types were presented according to the countries. The success of the method proposed in this study in the F1 Score was between 84% and 88% in datasets divided by country, while the total accuracy value was 87%.

The impact of COVID-19 on select considerations in patients of reproductive age: Brief talking points for pharmacists

BackgroundThe willingness to get COVID-19 or seasonal influenza vaccines has not yet been thoroughly investigated together, thus, this study aims to explore this notion within the general adult population.MethodsThe responses of 840 Hungarian participants were analysed who took part in a nationwide computer-assisted telephone interviewing. During the survey questions concerning various demographic characteristics, perceived financial status, and willingness to get the two types of vaccines were asked. Descriptive statistics, comparative statistics and word co-occurrence network analysis were conducted.Results48.2% of participants were willing to get a COVID-19 vaccine, while this ratio for the seasonal influenza was only 25.7%. The difference was significant. Regardless of how the participants were grouped, based on demographic data or perceived financial status, the significant difference always persisted. Being older than 59 years significantly increased the willingness to get both vaccines when compared to the middle-aged groups, but not when compared to the younger ones. Having higher education significantly elevated the acceptance of COVID-19 vaccination in comparison to secondary education. The willingness of getting any type of COVID-19 vaccine correlated with the willingness to get both influenza and COVID-19. Finally, those who were willing to get either vaccine coupled similar words together to describe their thoughts about a COVID-19 vaccination.ConclusionThe overall results show a clear preference for a COVID-19 vaccine and there are several similarities between the nature of willingness to get either type of vaccine.

Introduction: Influenza is a highly contagious viral infection that can lead to severe health complications, particularly in vulnerable populations, such as children and the elderly. The emergence of the coronavirus disease 2019 (COVID-19) pandemic shifted global attention toward combating the novel coronavirus, raising questions about the implications of COVID-19 vaccination on seasonal influenza infection rates. Therefore, the aim of this study is to assess whether receiving a COVID-19 vaccination is associated with a reduced incidence of seasonal influenza among university students at King Saud bin Abdulaziz University for Health Sciences (KSAU-HS) in Saudi Arabia. Materials and Methods: A cross-sectional study was conducted at KSAU-HS, utilizing a self-administered electronic questionnaire to gather data from 230 university students. The questionnaire collected demographic information, COVID-19 vaccination details, and influenza-related symptoms. Statistical analyses included descriptive statistics, Chi-square tests, and logistic regression to assess the relationship between vaccination status and influenza incidence. Results: Among the 230 university students, 134 (58.3%) reported not being infected with seasonal influenza, while 96 (41.7%) indicated that they had contracted the virus. A significant association was observed between gender and infection rates (P = 0.003), with males showing a higher infection rate (63.2%) than females (37.5%). Students who consistently wore masks had a significantly lower infection rate (32.6%, P = 0.049). Logistic regression analysis revealed that COVID-19 vaccination significantly reduced the odds of contracting influenza (odds ratio = 0.34, P = 0.001). Those vaccinated with the Pfizer-BioNTech vaccine exhibited lower infection rates (47.4%, P = 0.008) compared to other vaccine types. Kaplan–Meier survival analysis showed that students who contracted seasonal influenza after receiving the COVID-19 vaccine had a median illness duration of 2 days, while those who were not infected had a median of 3 days. Conclusion: COVID-19 vaccination appears to offer protective effects against seasonal influenza among university students. The findings highlight the importance of vaccination campaigns and preventive health measures to reduce respiratory infections in academic settings. Future research should further explore the interaction between COVID-19 and influenza vaccines to strengthen public health strategies.